Risk predictors of underestimation and the need for sentinel node biopsy in patients diagnosed with ductal carcinoma in situ by preoperative needle biopsy

Diagnosis of ductal carcinoma in situ (DCIS) by core needle biopsy showed a high rate of underestimation of invasiveness, and performing sentinel lymph node biopsy (SLNB) in DCIS patients was controversial.

[1]  D. Weaver,et al.  Limitation in gamma probe localization of the sentinel node in breast cancer patients with large excisional biopsy. , 1999, Journal of the American College of Surgeons.

[2]  S. Taplin,et al.  Variation in mammographic breast density by race. , 2001, Annals of epidemiology.

[3]  W. P. Evans,et al.  Stereotactic breast biopsy of nonpalpable lesions: determinants of ductal carcinoma in situ underestimation rates. , 2001, Radiology.

[4]  G. Farr,et al.  A Mass on Breast Imaging Predicts Coexisting Invasive Carcinoma in Patients with a Core Biopsy Diagnosis of Ductal Carcinoma in Situ , 2001, The American surgeon.

[5]  Umberto Veronesi,et al.  A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer. , 2003, The New England journal of medicine.

[6]  E. Darai,et al.  Subjective morbidity and quality of life after sentinel node biopsy and axillary lymph node dissection for breast cancer , 2005, Journal of surgical oncology.

[7]  A. Cantor,et al.  An update of sentinel lymph node mapping in patients with ductal carcinoma in situ. , 2005, American journal of surgery.

[8]  E. Winer,et al.  American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[9]  R. Mansel,et al.  Is there a role of sentinel lymph node biopsy in ductal carcinoma in situ?: analysis of 587 cases , 2006, Breast Cancer Research and Treatment.

[10]  PhD Facs Henry Mark Kuerer MD.  Con: Sentinel Lymph Node Biopsy for DCIS. The Breast Surgeon is not a Barber , 2006, Annals of Surgical Oncology.

[11]  H. Cody.  Sentinel Lymph Node Biopsy for DCIS: Are We Approaching Consensus? , 2007, Annals of Surgical Oncology.

[12]  J. Peterse,et al.  Risk of invasion and axillary lymph node metastasis in ductal carcinoma in situ diagnosed by core‐needle biopsy , 2007, The British journal of surgery.

[13]  A. Giuliano,et al.  Long-Term Morbidity of Sentinel Node Biopsy Versus Complete Axillary Dissection for Unilateral Breast Cancer , 2008, Annals of Surgical Oncology.

[14]  M. Ernst,et al.  The value of sentinel lymph node biopsy in ductal carcinoma in situ (DCIS) and DCIS with microinvasion of the breast. , 2008, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[15]  W. Han,et al.  Sonographic lesion size of ductal carcinoma in situ as a preoperative predictor for the presence of an invasive focus , 2008, Journal of surgical oncology.

[16]  G. Viale,et al.  Sentinel Node Biopsy Is Not a Standard Procedure in Ductal Carcinoma In Situ of the Breast: The Experience of the European Institute of Oncology on 854 Patients in 10 Years , 2008, Annals of surgery.

[17]  S. Mclaughlin,et al.  Prevalence of lymphedema in women with breast cancer 5 years after sentinel lymph node biopsy or axillary dissection: objective measurements. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[18]  S. Ogston,et al.  Meta‐analysis of sentinel node biopsy in ductal carcinoma in situ of the breast , 2008, The British journal of surgery.

[19]  M. Kerin,et al.  Sentinel lymph node biopsy in patients with a needle core biopsy diagnosis of ductal carcinoma in situ: is it justified? , 2009, Journal of Clinical Pathology.

[20]  D. Murawa,et al.  The role of sentinel node biopsy in ductal carcinoma in situ of the breast. , 2009, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[21]  E. Kurniawan,et al.  Risk factors for invasive breast cancer when core needle biopsy shows ductal carcinoma in situ. , 2010, Archives of surgery.

[22]  G. Hermann.  Ductal Carcinoma in Situ at Core-Needle Biopsy: Meta-Analysis of Underestimation and Predictors of Invasive Breast Cancer , 2012 .

[23]  H. Moon,et al.  Comparison of the underestimation rate in cases with ductal carcinoma in situ at ultrasound-guided core biopsy: 14-gauge automated core-needle biopsy vs 8- or 11-gauge vacuum-assisted biopsy. , 2012, The British journal of radiology.